跳至主要内容
临床试验/NCT07145567
NCT07145567招募中不适用

Microangiopathy IN Diabetes

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年3月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
1
主要终点
Peak perfusion in response to local thermal hyperemia

研究概览

简要总结

This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individuals and patients with microvascular disease associated with type 1 diabetes. It is hoped that the study results will lead to the development of a useful method for detecting diabetic complications at an early stage, thereby enabling treatment and preventive measures before the onset of severe microangiopathy.

详细描述

This study will employ investigational devices to evaluate microvascular function and correlate it to degree of microangiopathy in persons with diabetes type 1 and healthy controls.

The investigational device, TCI P4, is a novel, contactless, non-invasive, non-CE marked, class IIa Spatial Frequency Domain Imaging (SFDI) system. The device utilizes an LED light projector to cast patterned, multi-wavelength light onto the skin while multiple cameras capture narrow-band reflections. This method yields two-dimensional data on skin structure and molecular composition (including hemoglobin, oxygen, and water). Established comparators such as laser speckle contrast imaging (LSCI) and the EPOS system are employed to benchmark device performance and validate measurements.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetes mellitus type
  • Cohort specific inclusion criteria apply, please review 'groups' section.

排除标准

  • Patients unable to understand patient information due to cognitive impairment.
  • Patients unable to understand patient information due to language barriers.
  • Ongoing acute infection disease or inflammatory condition.
  • Pregnant or breast-feeding women.
  • Patients with damaged and/or scarred tissue in the areas of interest for the investigational or comparator devices.

结局指标

主要结局

Peak perfusion in response to local thermal hyperemia

时间窗: Investigation will take within 1 day from enrollment.

As measured with investigational devices TCI P4, Pericam LSCI and EPOS devices.

次要结局

  • Perfusion heterogeneity in sole of feet(Investigation will take place within 1 day from enrollment.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Tehrani

Principal investigator, Medical doctor, Specialist in internal medicine

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验

Microangiopathy in Diabetes | 临床试验